Pharmacy Data as an Alternative Data Source for Implementation of a Data to Care Strategy

被引:6
作者
Byrd, Kathy K. [1 ]
Camp, Nasima M. [2 ]
Iqbal, Kashif [1 ]
Weidle, Paul J. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, 1600 Clifton Rd,MS E-45, Atlanta, GA 30329 USA
[2] ICF, Dept Hlth Res Informat & Technol, Atlanta, GA USA
关键词
Data to Care; HIV; antiretroviral therapy; retention in care; pharmacy; ANTIRETROVIRAL THERAPY; ADHERENCE; INTERVENTION; INTERRUPTIONS; RESISTANCE; PATTERNS; IMPACT; TRIAL; TIME;
D O I
10.1097/QAI.0000000000001969
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Data to Care (D2C) is a strategy for using health departments' HIV surveillance data (HIV viral load and CD4 laboratory reports) to identify and re-engage not-in-care persons with HIV. In the current D2C model, there is a delay in the identification of persons not in care due to the time interval between recommended monitoring tests (ie, every 3-6 months) and the subsequent reporting of these tests to the health department. Methods: Pharmacy claims and fulfillment data can be used to identify persons with HIV who have stopped filling antiretroviral therapy and are at risk of falling out of care. Because most antiretrovirals (ARVs) are prescribed as a 30-day supply of medication, these data can be used to identify persons who are not filling their medications on a monthly basis. The use of pharmacy claims data to identify persons not filling ARV prescriptions is an example of how "big data" can be used to conduct a modified D2C model. Results: Although a D2C strategy using pharmacy data has not been broadly implemented, a few health departments are implementing demonstration projects using this strategy. As the projects progress, processes and outcomes can be evaluated. Conclusions: Tracking ARV refill data can be a more real-time indicator of poor adherence and can help identify HIV-infected persons at risk of falling out of HIV medical care.
引用
收藏
页码:S53 / S56
页数:4
相关论文
共 23 条
  • [11] Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2016 Recommendations of the International Antiviral Society-USA Panel
    Gunthard, Huldrych F.
    Saag, Michael S.
    Benson, Constance A.
    del Rio, Carlos
    Eron, Joseph J.
    Gallant, Joel E.
    Hoy, Jennifer F.
    Mugavero, Michael J.
    Sax, Paul E.
    Thompson, Melanie A.
    Gandhi, Rajesh T.
    Landovitz, Raphael J.
    Smith, Davey M.
    Jacobsen, Donna M.
    Volberding, Paul A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (02): : 191 - 210
  • [12] Haberer JE, 2015, JAIDS-J ACQ IMM DEF, V70, P386, DOI 10.1097/QAI.0000000000000737
  • [13] Antiretroviral treatment among commercially insured persons living with HIV in an era of universal treatment in the United States-2012-2014
    Iqbal, Kashif
    Huang, Ya-lin A.
    Peters, Philip
    Weidle, Paul
    Hoover, Karen
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (09): : 1128 - 1134
  • [14] Improvements in HIV Care Engagement and Viral Load Suppression Following Enrollment in a Comprehensive HIV Care Coordination Program
    Irvine, Mary K.
    Chamberlin, Stephanie A.
    Robbins, Rebekkah S.
    Myers, Julie E.
    Braunstein, Sarah L.
    Mitts, Beau J.
    Harriman, Graham A.
    Nash, Denis
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (02) : 298 - 310
  • [15] Effects of unplanned treatment interruptions on HIV treatment failure - results from TAHOD
    Jiamsakul, Awachana
    Kerr, Stephen J.
    Ng, Oon Tek
    Lee, Man Po
    Chaiwarith, Romanee
    Yunihastuti, Evy
    Kinh Van Nguyen
    Thuy Thanh Pham
    Kiertiburanakul, Sasisopin
    Ditangco, Rossana
    Saphonn, Vonthanak
    Sim, Benedict L. H.
    Merati, Tuti Parwati
    Wong, Wingwai
    Kantipong, Pacharee
    Zhang, Fujie
    Choi, Jun Yong
    Pujari, Sanjay
    Kamarulzaman, Adeeba
    Oka, Shinichi
    Mustafa, Mahiran
    Ratanasuwan, Winai
    Petersen, Boondarika
    Law, Matthew
    Kumarasamy, Nagalingeswaran
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2016, 21 (05) : 662 - 674
  • [16] Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up
    Knobel, H.
    Urbina, O.
    Gonzalez, A.
    Sorli, M. L.
    Montero, M.
    Carmona, A.
    Guelar, A.
    [J]. HIV MEDICINE, 2009, 10 (06) : 364 - 369
  • [17] Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon
    Meresse, M.
    March, L.
    Kouanfack, C.
    Bonono, R-C
    Boyer, S.
    Laborde-Balen, G.
    Aghokeng, A.
    Suzan-Monti, M.
    Delaporte, E.
    Spire, B.
    Carrieri, M-P
    Laurent, C.
    [J]. HIV MEDICINE, 2014, 15 (08) : 478 - 487
  • [18] Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance
    Sethi, AK
    Celentano, DD
    Gange, SJ
    Moore, RD
    Gallant, JE
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (08) : 1112 - 1118
  • [19] Impact of late-to-refill reminder calls on medication adherence in the Medicare Part D population: evaluation of a randomized controlled study
    Taitel, Michael S.
    Mu, Ying
    Gooptu, Angshuman
    Lou, Youbei
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 373 - 379
  • [20] Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions
    Tinago, W.
    O'Halloran, J. A.
    O'Halloran, R. M.
    Macken, A.
    Lambert, J. S.
    Sheehan, G. J.
    Mallon, P. W. G.
    [J]. HIV MEDICINE, 2014, 15 (04) : 224 - 232